| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Ezine Publishing > OK People - Let's Get Real! |
|
Just Other Articles - OK People - Let's Get Real!
It's all about numbers - or so some ezine publishers would have you believe. 10,000 subscribers and counting! According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product 20,000 subscribers and counting! 30,000 subscribers and counting! You get the picture...or do you? Now let me ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ask you - how many of those are actually READING your newsletter? Do you even know? Have you checked? You might lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. really be surprised! I've got bad news - especially for those publishers who use free ads to entice their readers t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe o subscribe. If your publication is business-oriented, you're lucky if 10% ever lay eyes on that wonderful work you d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro labored so long over. And if it's filled with dozens and dozens of ads from all the free and low-cost ad placement ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc programs now available, I have three words for you - - can you say, "scan and delete?" Because that's exactly what easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi the majority of your subscribers are doing. I promise. That is, those who are even GETTING your newsletter. Now I nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically know that most of you, especially the ones who are currently still running those free ads, know that what I am sayi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ng is true. Yet there are those among you that insist on hanging on to all those precious subscriber email addresse ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s for dear life (even the ones that have bounced five times) on the outside chance that one day that email will glor ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a iously begin to start accepting mail again and your count will be a true one. Fat chance. I'm not saying that all dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod publishers do this; I know many that clean their lists on a regular basis. The long-time publishers who have grown cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin their lists by traditional means certainly do. That's why they can command good prices for advertising - and get it tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . But how many of you have the guts to do what I did? MAKE THEM RE-CONFIRM EVERY YEAR. Go ahead - I challenge you t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel . Make them take some sort of action that REQUIRES them to say "Yes, keep me on your list." Or else they don't get ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the newsletter. Period. No exceptions. Watch those subscriber numbers drop like a rock - and watch your "open ra y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products te" climb. Because what you're really after is sustained, loyal readership. Trusting subscribers who know that you . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de are going to provide them with good, solid information. And you're going to have to give it to them - otherwise, y elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ou'll never accomplish what it is you intended to do when you started publishing your newsletter. Like making money tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Internet Home Business Idea - Starting Your Own Ebay Store
|